BIRC5 and hepatocellular carcinoma: Our current study demonstrated that myricetin induced LATS1/2 activation, YAP phosphorylation and degradation, survivin inhibition, and caspase 3 cleavage, and subsequently induced proliferation inhibition and apoptosis of HCC cells (Figure 7).